PURPOSE: To demonstrate the capability of SD-OCT to measure macular retinal ganglion cell-inner plexiform layer (GCIPL) thickness and to assess its reproducibility in glaucomatous eyes. METHODS: Fifty-one glaucomatous eyes (26 mild, 11 moderate, 14 severe) of 51 patients underwent macular scanning using the Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) macula 200×200 acquisition protocol. Five scans were obtained on 5 days within 2 months. The ganglion cell analysis (GCA) algorithm was used to detect the macular GCIPL and to measure the thickness of the overall average, minimum, superotemporal, superior, superonasal, inferonasal, inferior, and inferotemporal GCIPL. The reproducibility of the measurements was evaluated with intraclass correlation coefficients (ICCs), coefficients of variation (COVs), and test-retest standard deviations (TRTSDs). RESULTS: Segmentation and measurement of GCIPL thickness were successful in 50 of 51 subjects. All ICCs ranged between 0.94 and 0.98, but ICCs for average and superior GCIPL parameters (0.97-0.98) were slightly higher than for inferior GCIPL parameters (0.94-0.97). All COVs were <5%, with 1.8% for average GCIPL and COVs for superior GCIPL parameters (2.2%-3.0%) slightly lower than those for inferior GCIPL parameters (2.5%-3.6%). The TRTSD was lowest for average GCIPL (1.16 μm) and varied from 1.43 to 2.15 μm for sectoral GCIPL CONCLUSIONS: The Cirrus HD-OCT GCA algorithm can successfully segment macular GCIPL and measure GCIPL thickness with excellent intervisit reproducibility. Longitudinal monitoring of GCIPL thickness may be possible with Cirrus HD-OCT for assessing glaucoma progression.
PURPOSE: To demonstrate the capability of SD-OCT to measure macular retinal ganglion cell-inner plexiform layer (GCIPL) thickness and to assess its reproducibility in glaucomatous eyes. METHODS: Fifty-one glaucomatous eyes (26 mild, 11 moderate, 14 severe) of 51 patients underwent macular scanning using the Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) macula 200×200 acquisition protocol. Five scans were obtained on 5 days within 2 months. The ganglion cell analysis (GCA) algorithm was used to detect the macular GCIPL and to measure the thickness of the overall average, minimum, superotemporal, superior, superonasal, inferonasal, inferior, and inferotemporal GCIPL. The reproducibility of the measurements was evaluated with intraclass correlation coefficients (ICCs), coefficients of variation (COVs), and test-retest standard deviations (TRTSDs). RESULTS: Segmentation and measurement of GCIPL thickness were successful in 50 of 51 subjects. All ICCs ranged between 0.94 and 0.98, but ICCs for average and superior GCIPL parameters (0.97-0.98) were slightly higher than for inferior GCIPL parameters (0.94-0.97). All COVs were <5%, with 1.8% for average GCIPL and COVs for superior GCIPL parameters (2.2%-3.0%) slightly lower than those for inferior GCIPL parameters (2.5%-3.6%). The TRTSD was lowest for average GCIPL (1.16 μm) and varied from 1.43 to 2.15 μm for sectoral GCIPL CONCLUSIONS: The Cirrus HD-OCT GCA algorithm can successfully segment macular GCIPL and measure GCIPL thickness with excellent intervisit reproducibility. Longitudinal monitoring of GCIPL thickness may be possible with Cirrus HD-OCT for assessing glaucoma progression.
Authors: Vedran Kajić; Boris Povazay; Boris Hermann; Bernd Hofer; David Marshall; Paul L Rosin; Wolfgang Drexler Journal: Opt Express Date: 2010-07-05 Impact factor: 3.894
Authors: L J Frishman; F F Shen; L Du; J G Robson; R S Harwerth; E L Smith; L Carter-Dawson; M L Crawford Journal: Invest Ophthalmol Vis Sci Date: 1996-01 Impact factor: 4.799
Authors: Hiroshi Ishikawa; Daniel M Stein; Gadi Wollstein; Siobahn Beaton; James G Fujimoto; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2005-06 Impact factor: 4.799
Authors: Ahmet Murat Bagci; Mahnaz Shahidi; Rashid Ansari; Michael Blair; Norman Paul Blair; Ruth Zelkha Journal: Am J Ophthalmol Date: 2008-08-15 Impact factor: 5.258
Authors: Gadi Wollstein; Joel S Schuman; Lori L Price; Ali Aydin; Siobahn A Beaton; Paul C Stark; James G Fujimoto; Hiroshi Ishikawa Journal: Am J Ophthalmol Date: 2004-08 Impact factor: 5.258
Authors: Stephanie J Chiu; Xiao T Li; Peter Nicholas; Cynthia A Toth; Joseph A Izatt; Sina Farsiu Journal: Opt Express Date: 2010-08-30 Impact factor: 3.894
Authors: E Ann Yeh; Ruth Ann Marrie; Y Arun Reginald; J Raymond Buncic; Austin E Noguera; Julia O'Mahony; Jean K Mah; Brenda Banwell; Fiona Costello Journal: Neurology Date: 2014-10-31 Impact factor: 9.910
Authors: P Carpineto; L Toto; R Aloia; V Ciciarelli; E Borrelli; E Vitacolonna; M Di Nicola; L Di Antonio; R Mastropasqua Journal: Eye (Lond) Date: 2016-02-12 Impact factor: 3.775
Authors: Hrvoje Bogunović; Young H Kwon; Adnan Rashid; Kyungmoo Lee; Douglas B Critser; Mona K Garvin; Milan Sonka; Michael D Abràmoff Journal: Invest Ophthalmol Vis Sci Date: 2014-12-09 Impact factor: 4.799
Authors: Jean-Claude Mwanza; Donald L Budenz; Joshua L Warren; Aaron D Webel; Courtney E Reynolds; Diego T Barbosa; Shan Lin Journal: Br J Ophthalmol Date: 2014-12-09 Impact factor: 4.638
Authors: Ahmad A Aref; Fouad E Sayyad; Jean-Claude Mwanza; William J Feuer; Donald L Budenz Journal: J Glaucoma Date: 2014 Oct-Nov Impact factor: 2.503
Authors: Vittorio Porciatti; Brandon Bosse; Prashant K Parekh; Olga A Shif; William J Feuer; Lori M Ventura Journal: J Glaucoma Date: 2014 Oct-Nov Impact factor: 2.503